The 12- and 24-Month Effects of Intravitreal Ranibizumab, Aflibercept, and Bevacizumab on Intraocular Pressure: A Network Meta-Analysis.
Nanji K, Sarohia GS, Kennedy K, Ceyhan T, McKechnie T, Phillips M, Devji T, Thabane L, Kaiser P, Sarraf D, Garg SJ, Sivaprasad S, Wykoff CC, Bakri SJ, Sheidow T, Bhandari M, Chaudhary V.
Nanji K, et al. Among authors: chaudhary v.
Ophthalmology. 2022 May;129(5):498-508. doi: 10.1016/j.ophtha.2021.11.024. Epub 2021 Dec 4.
Ophthalmology. 2022.
PMID: 34871637